1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012